Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1985 Apr;48(4):332–337. doi: 10.1136/jnnp.48.4.332

Thymectomy in myasthenia with pure ocular symptoms.

F Schumm, H Wiethölter, A Fateh-Moghadam, J Dichgans
PMCID: PMC1028297  PMID: 3998738

Abstract

Eighteen patients with exclusively ocular symptoms of myasthenia were thymectomised. Suspected thymoma, resistance to pyridostigmine therapy or relapse following immunosuppressive therapy were taken as indications for surgery. The mean preoperative observation period before operation was 40 months, and after operation was 26 months. There was no operative or postoperative morbidity or mortality. Histological thymic abnormalities were found in all patients (in one case, thymoma; in four, persistent thymus; in 13, thymic hyperplasia). The histological abnormalities were identical to those found in generalised myasthenia. This included the distribution of T-cell subtypes as identified by use of monoclonal antibodies. The severity of ocular symptoms was rated using a score developed for this purpose. The score progressively declined after surgery to an average of 70% of its initial amount in 80% of patients. Full remission occurred in three cases. No patient developed generalized myasthenia. Antibody titres against acetylcholine receptors if elevated preoperatively also dropped following surgery, with one exception. Clear criteria for the expected therapeutic success of thymectomy could not be identified. Based on our results, and on the assumed significance of the thymus gland for pathogenesis, thymectomy should be considered in patients with pure ocular symptoms.

Full text

PDF
332

Images in this article

335Image
on p.335
336Image
on p.336

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buckingham J. M., Howard F. M., Jr, Bernatz P. E., Payne W. S., Harrison E. G., Jr, O'Brien P. C., Weiland L. H. The value of thymectomy in myasthenia gravis: a computer-assisted matched study. Ann Surg. 1976 Oct;184(4):453–458. doi: 10.1097/00000658-197610000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Conti-Tronconi B. M., Scotti A., Sghirlanzoni A., Clementi F. Specific involvement of peripheral T lymphocytes against acetylcholine receptors in myasthenia gravis. J Neurol Neurosurg Psychiatry. 1983 Sep;46(9):832–836. doi: 10.1136/jnnp.46.9.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Emeryk B., Strugalska M. H. Evaluation of results of thymectomy in myasthenia gravis. J Neurol. 1976 Jan 14;211(2):155–168. doi: 10.1007/BF00313359. [DOI] [PubMed] [Google Scholar]
  4. Fraser K., Simpson J. A., Crawford J. The place of surgery in the treatment of myasthenia gravis. Br J Surg. 1978 May;65(5):301–304. doi: 10.1002/bjs.1800650503. [DOI] [PubMed] [Google Scholar]
  5. Fujii N., Itoyama Y., Tabira T., Kuroiwa Y. Subsets of lymphoid cells in blood and thymus in myasthenia gravis. Monoclonal antibody analysis. J Neuroimmunol. 1983 Jun;4(3):151–159. doi: 10.1016/0165-5728(83)90031-0. [DOI] [PubMed] [Google Scholar]
  6. Genkins G., Papatestas A. E., Horowitz S. H., Kornfield P. Studies in myasthenia gravis: early thymectomy. Electrophysiologic and pathologic correlations. Am J Med. 1975 Apr;58(4):517–524. doi: 10.1016/0002-9343(75)90125-4. [DOI] [PubMed] [Google Scholar]
  7. Havard C. W., Scadding G. K. Myasthenia gravis. Pathogenesis and current concepts in management. Drugs. 1983 Aug;26(2):174–184. doi: 10.2165/00003495-198326020-00004. [DOI] [PubMed] [Google Scholar]
  8. Howard F. M., Jr, Duane D. D., Lambert E. H., Daube J. R. Alternate-day prednisone: preliminary report of a double-blind controlled study. Ann N Y Acad Sci. 1976;274:596–607. doi: 10.1111/j.1749-6632.1976.tb47718.x. [DOI] [PubMed] [Google Scholar]
  9. Kunze K. Thymectomy in the treatment of myasthenia. Thorac Cardiovasc Surg. 1980 Dec;28(6):380–385. doi: 10.1055/s-2007-1022439. [DOI] [PubMed] [Google Scholar]
  10. Mulder D. G., Herrmann C., Jr, Keesey J., Edwards H. Thymectomy for myasthenia gravis. Am J Surg. 1983 Jul;146(1):61–66. doi: 10.1016/0002-9610(83)90260-x. [DOI] [PubMed] [Google Scholar]
  11. Papatestas A. E., Genkins G., Horowitz S. H., Kornfeld P. Thymectomy in myasthenia gravis: pathologic, clinical, and electrophysiologic correlations. Ann N Y Acad Sci. 1976;274:555–573. doi: 10.1111/j.1749-6632.1976.tb47715.x. [DOI] [PubMed] [Google Scholar]
  12. Rodriguez M., Gomez M. R., Howard F. M., Jr, Taylor W. F. Myasthenia gravis in children: long-term follow-up. Ann Neurol. 1983 May;13(5):504–510. doi: 10.1002/ana.410130506. [DOI] [PubMed] [Google Scholar]
  13. Rowland L. P. Controversies about the treatment of myasthenia gravis. J Neurol Neurosurg Psychiatry. 1980 Jul;43(7):644–659. doi: 10.1136/jnnp.43.7.644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Schumm F., Stöhr M. Accessory nerve stimulation in the assessment of myasthenia gravis. Muscle Nerve. 1984 Feb;7(2):147–151. doi: 10.1002/mus.880070211. [DOI] [PubMed] [Google Scholar]
  15. Scoppetta C., Tonali P., Evoli A., David P., Crucitti F., Vaccario M. L. Treatment of myasthenia gravis. Report on 139 patients. J Neurol. 1979;222(1):11–21. doi: 10.1007/BF00313263. [DOI] [PubMed] [Google Scholar]
  16. Seybold M. E., Lindstrom J. M. Immunopathology of acetylcholine receptors in myasthenia gravis. Springer Semin Immunopathol. 1982;5(4):389–412. doi: 10.1007/BF01857427. [DOI] [PubMed] [Google Scholar]
  17. Thomas J. A., Willcox H. N., Newsom-Davis J. Immunohistological studies of the thymus in myasthenia gravis. Correlation with clinical state and thymocyte culture responses. J Neuroimmunol. 1982 Dec;3(4):319–335. doi: 10.1016/0165-5728(82)90035-2. [DOI] [PubMed] [Google Scholar]
  18. Vincent A., Newsom-Davis J. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles. Clin Exp Immunol. 1982 Aug;49(2):257–265. [PMC free article] [PubMed] [Google Scholar]
  19. Wekerle H., Hohlfeld R., Ketelsen U. P., Kalden J. R., Kalies I. Thymic myogenesis, T-lymphocytes and the pathogenesis of myasthenia gravis. Ann N Y Acad Sci. 1981;377:455–476. doi: 10.1111/j.1749-6632.1981.tb33753.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES